These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25746101)

  • 1. Deacetylation of chromatin and gene expression regulation: a new target for epigenetic therapy.
    Olzscha H; Sheikh S; La Thangue NB
    Crit Rev Oncog; 2015; 20(1-2):1-17. PubMed ID: 25746101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart Failure.
    Evans LW; Ferguson BS
    Nutrients; 2018 Aug; 10(8):. PubMed ID: 30126190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylases (HDACs): characterization of the classical HDAC family.
    de Ruijter AJ; van Gennip AH; Caron HN; Kemp S; van Kuilenburg AB
    Biochem J; 2003 Mar; 370(Pt 3):737-49. PubMed ID: 12429021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
    Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A
    Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking epigenetics to lipid metabolism: focus on histone deacetylases.
    Ferrari A; Fiorino E; Giudici M; Gilardi F; Galmozzi A; Mitro N; Cermenati G; Godio C; Caruso D; De Fabiani E; Crestani M
    Mol Membr Biol; 2012 Nov; 29(7):257-66. PubMed ID: 23095054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylases as targets in autoimmune and autoinflammatory diseases.
    Hamminger P; Rica R; Ellmeier W
    Adv Immunol; 2020; 147():1-59. PubMed ID: 32981634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation in chondrogenesis.
    Furumatsu T; Ozaki T
    Acta Med Okayama; 2010 Jun; 64(3):155-61. PubMed ID: 20596126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigenetics.
    Hadnagy A; Beaulieu R; Balicki D
    Mol Cancer Ther; 2008 Apr; 7(4):740-8. PubMed ID: 18413789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
    Ramaiah MJ; Tangutur AD; Manyam RR
    Life Sci; 2021 Jul; 277():119504. PubMed ID: 33872660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress, thiol redox signaling methods in epigenetics.
    Sundar IK; Caito S; Yao H; Rahman I
    Methods Enzymol; 2010; 474():213-44. PubMed ID: 20609913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic evidence of an Ac/Dc axis by VPA and SAHA.
    Lunke S; Maxwell S; Khurana I; K N H; Okabe J; Al-Hasani K; El-Osta A
    Clin Epigenetics; 2021 Mar; 13(1):58. PubMed ID: 33743782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone Acetylation Enzymes Coordinate Metabolism and Gene Expression.
    Shen Y; Wei W; Zhou DX
    Trends Plant Sci; 2015 Oct; 20(10):614-621. PubMed ID: 26440431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
    Hutt DM; Roth DM; Marchal C; Bouchecareilh M
    Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target].
    Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M
    Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an epigenetic signature of early mouse liver regeneration that is disrupted by Zn-HDAC inhibition.
    Huang J; Schriefer AE; Yang W; Cliften PF; Rudnick DA
    Epigenetics; 2014 Nov; 9(11):1521-31. PubMed ID: 25482284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application.
    Santini V; Gozzini A; Ferrari G
    Curr Drug Metab; 2007 May; 8(4):383-93. PubMed ID: 17504226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics.
    Gallinari P; Di Marco S; Jones P; Pallaoro M; Steinkühler C
    Cell Res; 2007 Mar; 17(3):195-211. PubMed ID: 17325692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of dietary histone deacetylases (HDACs) inhibitors in health and disease.
    Bassett SA; Barnett MP
    Nutrients; 2014 Oct; 6(10):4273-301. PubMed ID: 25322459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders.
    Konsoula Z; Barile FA
    J Pharmacol Toxicol Methods; 2012; 66(3):215-20. PubMed ID: 22902970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.